讲座信息
题目:Evaluation of Combination Therapy amid Patient-Level Heterogeneity
报告人:郭心舟(香港科技大学)
时间:2026.08.19 19:30
联系人:吴鹏(北京工商大学)
报告摘要
Combination therapy, the treatment approach that involves two or more monotherapies, is widely considered to enhance therapeutic efficacy for different conditions. It is usually believed that the combination therapy is beneficial because there exists a synergy/additive effect between the monotherapies it consists of. However, by lab experiments, pharmacologists recently noted that the benefit of some combination therapies might be largely driven by the varying patient-level responses to the monotherapies they consist of. Without taking such patient-level heterogeneity into account, the classical statistical inference framework for combination therapy might be inadequate and overly optimistic. In this paper, we introduce a new statistical inference framework to evaluate the combination therapy after adjusting for patient-level heterogeneity of monotherapies in a model-free manner. We address the non-identifiability, non-smoothness and non-linearity issue inherent in patient-level heterogeneity adjustment, and establish (partial) identifiability conditions of the cross-world target parameter. We develop an outcome-based optimal-matching scheme to achieve normal asymptotics and
confidence intervals for the target parameter, thereby enabling reliable and efficient evaluation of the combination therapy amid patient-level heterogeneity. The benefit of the proposed framework is demonstrated by a re-analysis of the ACTG 175 trial.
报告人简介
Xinzhou Guo is an Assistant Professor in the Department of Mathematics at the Hong Kong University of Science and Technology. He received his B.S. in Applied Mathematics from Peking University and Ph.D. in Statistics from the University of Michigan. Prior to joining HKUST in 2021, he did a postdoc at Harvard University. His main research interests are subgroup analysis, resampling methods, precision medicine and regulatory decision-making.